Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Opthea Limited

OPTNASDAQ
Healthcare
Biotechnology
$3.41
$0.05(1.49%)
U.S. Market is Open • 12:30

Opthea Limited Fundamental Analysis

Opthea Limited (OPT) shows moderate financial fundamentals with a PE ratio of -4.55, profit margin of -6511.64%, and ROE of 88.05%. The company generates $0.0B in annual revenue with weak year-over-year growth of -22.65%.

Key Strengths

ROE88.05%
PEG Ratio-0.07

Areas of Concern

Operating Margin-6230.48%
Current Ratio0.14
We analyze OPT's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -488344.3/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-488344.3/100

We analyze OPT's fundamental strength across five key dimensions:

Efficiency Score

Weak

OPT struggles to generate sufficient returns from assets.

ROA > 10%
-2.87%

Valuation Score

Excellent

OPT trades at attractive valuation levels.

PE < 25
-4.55
PEG Ratio < 2
-0.07

Growth Score

Moderate

OPT shows steady but slowing expansion.

Revenue Growth > 5%
-22.65%
EPS Growth > 10%
22.22%

Financial Health Score

Moderate

OPT shows balanced financial health with some risks.

Debt/Equity < 1
-1.23
Current Ratio > 1
0.14

Profitability Score

Weak

OPT struggles to sustain strong margins.

ROE > 15%
88.05%
Net Margin ≥ 15%
-6511.64%
Positive Free Cash Flow
No

Key Financial Metrics

Is OPT Expensive or Cheap?

P/E Ratio

OPT trades at -4.55 times earnings. This suggests potential undervaluation.

-4.55

PEG Ratio

When adjusting for growth, OPT's PEG of -0.07 indicates potential undervaluation.

-0.07

Price to Book

The market values Opthea Limited at -3.68 times its book value. This may indicate undervaluation.

-3.68

EV/EBITDA

Enterprise value stands at -25.98 times EBITDA. This is generally considered low.

-25.98

How Well Does OPT Make Money?

Net Profit Margin

For every $100 in sales, Opthea Limited keeps $-6511.64 as profit after all expenses.

-6511.64%

Operating Margin

Core operations generate -6230.48 in profit for every $100 in revenue, before interest and taxes.

-6230.48%

ROE

Management delivers $88.05 in profit for every $100 of shareholder equity.

88.05%

ROA

Opthea Limited generates $-2.87 in profit for every $100 in assets, demonstrating efficient asset deployment.

-2.87%

Following the Money - Real Cash Generation

Operating Cash Flow

Opthea Limited generates limited operating cash flow of $-951.41M, signaling weaker underlying cash strength.

$-951.41M

Free Cash Flow

Opthea Limited generates weak or negative free cash flow of $-1.35B, restricting financial flexibility.

$-1.35B

FCF Per Share

Each share generates $-1.09 in free cash annually.

$-1.09

FCF Yield

OPT converts -2.79% of its market value into free cash.

-2.79%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-4.55

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.07

vs 25 benchmark

P/B Ratio

Price to book value ratio

-3.68

vs 25 benchmark

P/S Ratio

Price to sales ratio

239246.86

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-1.23

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.14

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.88

vs 25 benchmark

ROA

Return on assets percentage

-2.87

vs 25 benchmark

ROCE

Return on capital employed

0.46

vs 25 benchmark

How OPT Stacks Against Its Sector Peers

MetricOPT ValueSector AveragePerformance
P/E Ratio-4.5529.43 Better (Cheaper)
ROE88.05%800.00% Weak
Net Margin-651164.00%-20145.00% (disorted) Weak
Debt/Equity-1.230.30 Strong (Low Leverage)
Current Ratio0.144.64 Weak Liquidity
ROA-286.61%-17936.00% (disorted) Weak

OPT outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Opthea Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

-59.58%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

-284.20%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-142.85%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ